Clinical Coagulation, Malmö
361 – 370 of 659
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
- Contribution to journal › Article
-
Mark
Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?
- Contribution to journal › Letter
-
Mark
A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use.
- Contribution to journal › Article
-
Mark
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
- Contribution to journal › Article
-
Mark
Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy.
- Contribution to journal › Article
-
Mark
New treatments in hemophilia: insights for the clinician.
- Contribution to journal › Article
-
Mark
Von Willebrand disease.
(2012) In Pediatric Blood & Cancer
- Contribution to journal › Article
-
Mark
The international factor IX treatment network survey.
- Contribution to journal › Letter
-
Mark
Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A.
(2012) In Haemophilia
- Contribution to journal › Article
-
Mark
von Willebrand's disease: a report from a meeting in the Åland islands.
- Contribution to journal › Article